Picard Medical, Inc. (PMI) Form 8-K — Nov 3, 2026
Picard Medical's board appointed Richard Fang, Ph.D., as permanent CEO effective October 28, 2026, ending his interim tenure that began June 18, 2026. Dr. Fang remains Chairman and previously served as CEO from September 2021 to July 2023, with his $0.4 million salary unchanged and no new compensation arrangements. The filing also discloses related-party financing: $0.7 million borrowed in February 2026 from Fang Family Fund I, LLC at 6% interest, due February 28, 2027, plus $0.5 million of interest-free loans from Fang Family Fund, LLC - Series II between July and October 2026.
Key figures
- External funding trigger usd
- 1000000
- Fang fund series ii interest
- 0%
- Fang fund loan feb 2026 interest
- 6%
- Fang fund loan feb 2026 maturity
- 2027-02-28
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.